Bldg. 1066 first floor repository
Ended Awarded Last action
- Contract number
- HHSN26100044
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $749,770
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $749,770.31 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $6,197 | |
| Other Administrative Action | $0 | |
| Original award | $743,573 |
About this award
This is a federal contract award by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The $749,770.31 contract is a cost-plus-fixed-fee Delivery Order with a completion date of September 24, 2023 for work related to the BLDG. 1066 FIRST FLOOR REPOSITORY.
Leidos Biomedical Research is a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer Institute, providing a broad range of biomedical research and facilities support services through task orders under a $6.6 billion indefinite delivery contract. This specific award appears to be one such task order, though the exact nature of the work is not specified. Leidos Biomedical Research also has a history of serving as a prime and subcontractor on various NIH research projects and initiatives, including in areas like cancer, HIV/AIDS, influenza, COVID-19, and gene therapy.
Quick answers
Who was awarded contract HHSN26100044?
HHSN26100044 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 29, 2017.
How much is contract HHSN26100044 worth?
The government has obligated $749,770 on HHSN26100044.
Is contract HHSN26100044 an order under another contract?
Yes. HHSN26100044 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100044 competed?
The extent of competition for HHSN26100044 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award